Literature DB >> 13884068

Optic nerve involvement associated with thyroid dysfunction.

R M DAY, F D CARROLL.   

Abstract

Entities:  

Keywords:  OPTIC NERVE/diseases

Mesh:

Year:  1961        PMID: 13884068      PMCID: PMC1316408     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


× No keyword cloud information.
  8 in total

1.  Changes in ocular rigidity in endocrine exophthalmos.

Authors:  R WEEKERS; G LAVERGNE
Journal:  Br J Ophthalmol       Date:  1958-11       Impact factor: 4.638

2.  Visual field defects in exophthalmos associated with thyroid disease.

Authors:  T R HEDGES; H G SCHEIE
Journal:  AMA Arch Ophthalmol       Date:  1955-12

3.  Visual changes in progressive exophthalmos.

Authors:  J IGERSHEIMER
Journal:  AMA Arch Ophthalmol       Date:  1955-01

4.  Malignant exophthalmos.

Authors:  A E BRALEY
Journal:  Am J Ophthalmol       Date:  1953-09       Impact factor: 5.258

5.  Intractable exophthalmos in thyroid disease.

Authors:  J L POPPEN
Journal:  Postgrad Med       Date:  1953-08       Impact factor: 3.840

6.  Ocular Manifestations of Thyroid Disease: Current Concepts.

Authors:  R M Day
Journal:  Trans Am Ophthalmol Soc       Date:  1959

7.  Surgical treatment of hyperthyroidism.

Authors:  L W SLOAN
Journal:  N Y State J Med       Date:  1951-12-15

8.  Optic neuropathy of exophthalmic goiter (Graves' disease).

Authors:  J W HENDERSON
Journal:  AMA Arch Ophthalmol       Date:  1958-04
  8 in total
  3 in total

Review 1.  Steroids and the eye--indications and complications.

Authors:  W J Dinning
Journal:  Postgrad Med J       Date:  1976-10       Impact factor: 2.401

2.  Endocrine optic neuropathies.

Authors:  F Moro; F Drago
Journal:  Doc Ophthalmol       Date:  1980-10-15       Impact factor: 2.379

Review 3.  Imaging studies for diagnosing Graves' orbitopathy and dysthyroid optic neuropathy.

Authors:  Allan C Pieroni Gonçalves; Eloísa M M S Gebrim; Mário L R Monteiro
Journal:  Clinics (Sao Paulo)       Date:  2012-11       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.